P1005: A PHASE 1, OPEN-LABEL, DOSE-ESCALATION STUDY OF SELINEXOR PLUS RUXOLITINIB IN PATIENTS WITH TREATMENT-NAÏVE MYELOFIBROSIS
暂无分享,去创建一个
S. Tantravahi | K. Chamoun | A. Kishtagari | J. Prchal | E. Sbar | S. Tamir | K. Maher | S. Mohan | H. Ali | A. Mazumder | I. Karasik | L. Dugom | X. Wang